文献速递药疹与重症皮肤不良反应

Stevens-Johnson综合征与中毒性表皮坏死松解症对患者生活质量影响的解释性描述质性研究

The quality-of-life impact of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) on patients' lives: an interpretative descriptive qualitative study.
PubMed 文献 · Br J Dermatol · 2024-01-01

本研究采用解释性描述质性设计,对18名SJS/TEN成人患者进行深度半结构化访谈并用内容分析提炼主题。结果构建 psychosocial impacts 与 chronicity of sequelae 两大主题,显示SJS/TEN在心理、躯体、社会、教育及职业等多维度显著影响生活质量,出院后存在心理照护缺口与照护路径不连贯。

要点

  • SJS/TEN对生活质量的影响涵盖心理、躯体、社会、教育及职业多个维度。
  • 出院后患者面临心理照护缺口、照护路径不连贯及缺乏协调照护的挑战。
  • 建议将SJS/TEN视为慢性疾病并考虑出院后心理与生活质量评估。

核心结论

  • SJS/TEN对患者生活质量的多维度体验产生显著影响,包括心理、躯体、社会、教育及职业方面。
  • 出院后患者面临心理照护缺口、照护路径不连贯及缺乏协调照护的挑战。
  • 若将SJS/TEN视为慢性疾病,需研究其长期影响以制定提升生活质量的照护计划。

研究设计与样本

  • 采用解释性描述质性研究设计,目的性抽样纳入18名SJS/TEN成人患者。
  • 通过深度半结构化访谈收集资料,并采用内容分析法分析数据。

主要发现

  • 构建两大主题:心理社会影响(含「自我与他人」「对生活视角的改变」)与后遗症慢性化(含「多器官受累」「TEN的进一步后果」)。
  • SJS/TEN影响患者心理、躯体、社会、教育及职业等多方面生活质量体验。
  • 许多患者表达出院后面临心理照护缺口、照护路径不连贯及缺乏协调照护的挑战。

临床怎么用

  • 临床应将SJS/TEN视为可能长期影响生活质量的慢性疾病进行管理。
  • 出院后需考虑对患者进行心理与生活质量评估。
  • 需关注照护路径的连贯性与协调性,以弥补出院后心理照护缺口。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Much has been documented about the physical sequelae of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). While less documented, it is recognized that patients can have long-lasting psychological sequelae. There is a lack of qualitative research on the quality of life (QoL) experiences of adults who have been diagnosed with SJS/TEN. OBJECTIVES: To explore the experiences of adults who had SJS/TEN and how these experiences relate to their QoL. METHODS: Using an interpretative descriptive qualitative study, a purposive sample of 18 adults with SJS/TEN were interviewed using in-depth semi-structured interviews. Data were analysed using content analysis. RESULTS: Two themes were constructed, each with two categories. Theme 1 (Psychosocial Impacts) included the categories 'The self and others' and 'A changed perspective on life'. Theme 2 (Chronicity of Sequelae) comprised the categories 'Multi-organ involvement' and 'Further consequences of TEN'. CONCLUSIONS: Findings highlighted that SJS/TEN had a significant impact on the different QoL experiences of participants including psychological, physical, social, educational and occupational. Many expressed challenges they faced following discharge from hospital, including gaps in psychological care, navigating disjointed care pathways and lack of coordinated care. If SJS/TEN is viewed as a chronic condition, it is important that researchers and clinicians study the long-term effects of SJS/TEN on people's lives to aid in developing a plan of care to enhance the QoL for this cohort. Psychological and QoL assessments following discharge from hospital require consideration. Much has been documented about the physical complications of Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Although it is well known that people who experience these conditions can be affected by long-lasting psychological effects, there is a lack of research on the quality of life (QoL) of adults who have been diagnosed with SJS/TEN. This study looked at the experiences of adults who had SJS/TEN and how these experiences impacted their QoL. To do this, we interviewed 18 adults with SJS/TEN and analysed the discussions to identify themes. We found that SJS/TEN impacted all QoL experiences including psychological, physical, social, educational and occupational. This included facing challenges after being discharged from hospital, because of gaps in psychological support and care pathways, and from a lack of coordination of care. Overall, our study findings highlight the significant impact that SJS/TEN can have on a person’s QoL. There is a need for further research to focus on the long-term effects of these conditions, to enhance support and care for patients.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. O'Reilly P, Walsh S, Bunker CB, et al. The quality-of-life impact of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) on patients' lives: an interpretative descriptive qualitative study. Br J Dermatol. 2024. PMID: 39162027. doi:10.1093/bjd/ljae334

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。